1-9 of 9 results for subject:Pfizer
Librarians' tools
- Search time
- 0.303 seconds
- Solr query time
- 0.001 seconds
- Search query
- subject:Pfizer
- We searched for
- subject_t:Pfizer OR subject_ses:61578
Type
House
Session
Year
Department
Member
More
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Business, Innovation and Skills what discussions either orally or in writing he or his Ministers or officials in his Department have had with (a) Pfizer and (b) AstraZeneca in the last two months regarding any bid for AstraZeneca.
To ask the Secretary of State for Business, Innovation and Skills what discussions either orally or in writing he or his Ministers or officials in his Department have had with (a) Pfizer and (b) AstraZeneca in the last two months regarding any bid for AstraZeneca.
There are ongoing interactions at senior level between Ministers in the Department for Business, Innovation and Skills (BIS) and senior executives from both AstraZeneca and Pfizer as part of the Department’s wider interactions with the Life Sciences industry.
BIS Ministers have spoken with the chief executives and others from both companies in the last couple of weeks about recent market developments including the approaches from Pfizer to AstraZeneca.
Andrew Miller: To ask the Secretary of State for Business, Innovation and Skills what meetings he has had with representatives of Pfizer (a) before and (b) after its decision to close its research and development site in Kent. [38427] [Official Report, 4 February 2011, Vol. 522, c. 976W.] Letter of...
Andrew Miller: To ask the Secretary of State for Business, Innovation and Skills what meetings he has had with representatives of Pfizer (a) before and (b) after its decision to close its research and development site in Kent. [38427] [Official Report, 4 February 2011, Vol. 522, c. 976W.] Letter of...
Adjournment debate on the proposed closure of the Pfizer manufacturing plant at Sandwich.
Adjournment debate on the proposed closure of the Pfizer manufacturing plant at Sandwich.
I congratulate my hon. Friend the Member for South Thanet (Laura Sandys) on securing the debate. The presence of other hon. Members in the Chamber is a reminder of the strength of feeling in Kent about this issue. The important contribution of my hon. Friend the Member for Dover (Charlie...
I congratulate my hon. Friend the Member for South Thanet (Laura Sandys) on securing the debate. The presence of other hon. Members in the Chamber is a reminder of the strength of feeling in Kent about this issue. The important contribution of my hon. Friend the Member for Dover (Charlie...
To ask the Secretary of State for Business, Innovation and Skills whether the South East of England Regional Development Agency was (a) consulted and (b) asked to provide its expertise by his Department prior to his decision to establish a taskforce on the closure of Pfizer's site in Kent; and...
To ask the Secretary of State for Business, Innovation and Skills whether the South East of England Regional Development Agency was (a) consulted and (b) asked to provide its expertise by his Department prior to his decision to establish a taskforce on the closure of Pfizer's site in Kent; and...
To ask the Secretary of State for Business, Innovation and Skills when he was informed of the decision by Pfizer to close its site in Kent.
To ask the Secretary of State for Business, Innovation and Skills when he was informed of the decision by Pfizer to close its site in Kent.
To ask the Secretary of State for Business, Innovation and Skills what estimate his Department has made of the effects on the pharmaceutical industry in the UK of the decision by Pfizer to close its site in Kent
To ask the Secretary of State for Business, Innovation and Skills what estimate his Department has made of the effects on the pharmaceutical industry in the UK of the decision by Pfizer to close its site in Kent
To ask the Secretary of State for Business, Innovation and Skills what meetings he has had with representatives of Pfizer (a) before and (b) after its decision to close its research and development site in Kent.
To ask the Secretary of State for Business, Innovation and Skills what meetings he has had with representatives of Pfizer (a) before and (b) after its decision to close its research and development site in Kent.
To ask the Secretary of State for Business, Innovation and Skills if he will meet representatives of the Royal Society of Chemistry to discuss the implications for scientific research of the decision by Pfizer to close its site in Kent.
To ask the Secretary of State for Business, Innovation and Skills if he will meet representatives of the Royal Society of Chemistry to discuss the implications for scientific research of the decision by Pfizer to close its site in Kent.